Thomas H. Brannagan III, MD
On the web
Overview
Dr. Brannagan is the director of the Peripheral Neuropathy Center and co-director of the EMG laboratory at Columbia University Medical Center. He graduated from the University of Virginia and also received his medical degree from the University of Virginia in Charlottesville. He completed his Neurology residency training at the Neurological Institute of Columbia Presbyterian Medical Center between 1991 and 1994. He subsequently did a Neuromuscular EMG fellowship at Columbia, followed by a Neuroimmunology fellowship in the laboratory of Dr. Norman Latov. Prior to returning to Columbia, Dr. Brannagan was the director of the Diabetic Neuropathy Research center at Cornell University in New York City.
He is a member of the American Academy of Neurology, the American Neurological Association, as well as the American Association of Electrodiagnostic Medicine. He is also a member of the International Society of Amyloidosis and the Peripheral Nerve Society.
He currently sees patients with peripheral neuropathies and does electrodiagnostic studies, as well as conducts clinical research and clinical trials for new treatments for peripheral neuropathy, with a special interest in hereditary transthyretin amyloid polyneuropathy and chronic inflammatory demyelinating polyneuropathy (CIDP).
Areas of Expertise / Conditions Treated
- Amyloidosis
- Electromyography (EMG)
- Neuropathy
- Peripheral Neuropathy
Academic Appointments
- Professor of Neurology at CUMC
Administrative Titles
- Director, Peripheral Neuropathy Center
- Director, Columbia Neuropathy Research Center
- Co-director, Electromyography (EMG) Laboratory
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
- NYP Employee Plan
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- Internship: Beth Israel Medical Center
- Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Neuromuscular Medicine
- Neurology
- Clinical Neurophysiology
Research
Dr. Brannagan's major interest is in the evaluation and treatment of peripheral neuropathy, particularly immune-mediated neuropathies and idiopathic neuropathies. His publications have focused on new treatments for chronic demyelinating polyneuropathy (CIDP), painful neuropathies, neuropathy associated with celiac disease and the use of IVIg in Neurological disorders. He has participated in numerous clinical trials of new agents to treat patients with peripheral neuropathy.
For a complete list of publications, please visit PubMed.gov